Regencell Bioscience (RGC) had the highest return on January 7 by a large-cap US stock, returning 49.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 1/7/2026 | 49.84% |
Revolution Medicines (RVMD) | 1/7/2026 | 26.88% |
Credo Technology (CRDO) | 1/7/2026 | 9.45% |
Intel (INTC) | 1/7/2026 | 6.1% |
Amkor Technology (AMKR) | 1/7/2026 | 5.48% |
Legence Corp Class A Common stock (LGN) | 1/7/2026 | 5.34% |
Astera Labs (ALAB) | 1/7/2026 | 4.92% |
Exelixis (EXEL) | 1/7/2026 | 4.38% |
Oklo (OKLO) | 1/7/2026 | 4.27% |
Alnylam Pharmaceuticals (ALNY) | 1/7/2026 | 4.19% |
Alamos Gold (AGI) | 1/7/2026 | 4.18% |
Planet Labs PBC (PL) | 1/7/2026 | 4.1% |
Moderna (MRNA) | 1/7/2026 | 4.03% |
Lumentum (LITE) | 1/7/2026 | 3.93% |
Samsara (IOT) | 1/7/2026 | 3.74% |
Sandisk (SNDK) | 1/7/2026 | 3.72% |
Zscaler (ZS) | 1/7/2026 | 3.65% |
AbbVie (ABBV) | 1/7/2026 | 3.63% |
Globalfoundries (GFS) | 1/7/2026 | 3.57% |
MP Materials (MP) | 1/7/2026 | 3.48% |
Crowdstrike (CRWD) | 1/7/2026 | 3.44% |
Okta (OKTA) | 1/7/2026 | 3.42% |
Regeneron Pharmaceuticals (REGN) | 1/7/2026 | 3.32% |
Agnico Eagle Mines (AEM) | 1/7/2026 | 3.28% |
argenx NV ADR (ARGX) | 1/7/2026 | 3.28% |
Large-cap stocks are treated as having a market cap of $10B+.